Efficacy News and Research

RSS

Chronic kidney disease patients are excluded from clinical trials

Kidney diseases affect 850 million people worldwide, a figure twice as high as that of diabetes. Yet patients with chronic kidney disease are still being excluded from clinical trials.

10 Jul 2019

Herbal supplement used to treat addiction and pain is not safe, research says

The herb kratom is increasingly being used to manage pain and treat opioid addiction, but it's not safe to use as an herbal supplement, according to new research led by faculty at Binghamton University, State University of New York.

9 Jul 2019

Nutritional supplements offer no protection against cardiovascular diseases, say researchers

A new study warns that most dietary supplements do nothing to protect against cardiovascular diseases, including heart disease, stroke, and even heart attack.

9 Jul 2019

Antibiotic combination effective against drug-resistant Pseudomonas

Two well known and used antibiotics when combined have been found to be more effective against a deadly bacteria Pseudomonas aeruginosa, a common cause of hospital-based infections.

8 Jul 2019

Collagen powder found to be effective in wound closure

Collagen powder is just as effective in managing skin biopsy wounds as primary closure with non-absorbable sutures, according to a first-of-its-kind study published in the Journal of Drugs in Dermatology by a team of physician researchers at the George Washington University.

8 Jul 2019

ISTH introduces new global education initiative in gene therapy for hemophilia

The International Society on Thrombosis and Haemostasis is pleased to announce the official launch of Gene Therapy in Hemophilia: An ISTH Education Initiative.

8 Jul 2019

New drug combinations and dosing schedules improve outlook in advanced colon cancer

Advanced colon cancer often spreads widely and may not respond to standard chemotherapy. In such a case, a novel combination of drugs and flexible dosing may help achieve a better outlook, as demonstrated by several new studies.

8 Jul 2019

Study suggests usefulness of more flexible dose of regorafenib to relieve side-effects in mCRC patients

Medical oncologists administer anticancer drug regorafenib to try to improve overall survival in patients with metastatic colorectal cancer who have ceased to respond to standard therapy (known as refractory mCRC).

7 Jul 2019

Computer-generated flu vaccine enters clinical trials in the US

A seasonal flu vaccine that has been developed entirely by artificial intelligence on a computer is set to be tested in clinical trials in the US.

4 Jul 2019

Hesperos' multi-organ model correctly determine cardiotoxic mechanisms

Hesperos Inc., pioneers of the "human-on-a-chip" in vitro system has announced the use of its innovative multi-organ model to successfully measure the concentration and metabolism of two known cardiotoxic small molecules over time, to accurately describe the drug behavior and toxic effects in vivo.

4 Jul 2019

$FDA grants accelerated approval to new treatment for refractory multiple myeloma$

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Today, the U.S. Food and Drug Administration granted accelerated approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma who have received at least four prior therapies and whose disease is resistant to several other forms of treatment, including at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody.

3 Jul 2019

CMC expresses dismay at the findings of new report “Drugs policy: medicinal cannabis”

Today the Centre for Medicinal Cannabis has expressed dismay at the findings of the House of Commons Health and Social Care Committee report “Drugs policy: medicinal cannabis”.

3 Jul 2019

New telementoring program seeks to improve quality of care for breast cancer patients

A new program led by The University of Kansas Cancer Center seeks to improve community oncology providers' knowledge of genetic testing in breast cancer patients, as well as provide tools to allow genetic counseling and testing to be incorporated in their clinical practice.

2 Jul 2019

$Hypofractionated proton therapy for prostate cancer can be just as effective as standard treatment$

Hypofractionated proton therapy for prostate cancer can be just as effective as standard treatment

Treating prostate cancer with higher doses of proton therapy over a shorter amount of time leads to similar outcomes when compared to standard dose levels and treatments and is safe for patients, according to a new study examining the risk of long-term side-effects from the treatment.

2 Jul 2019

Georgia State researcher wins $3.26 million federal grant to develop universal flu vaccine

Influenza remains a major public health risk, and Dr. Baozhong Wang, associate professor in Georgia State University's Institute for Biomedical Sciences, has received a five-year, $3.26 million federal grant to combat this threat by developing a universal vaccine that offers more protection against influenza than seasonal vaccines.

2 Jul 2019

Efficacy News and Research

Chronic kidney disease patients are excluded from clinical trials

Herbal supplement used to treat addiction and pain is not safe, research says

Nutritional supplements offer no protection against cardiovascular diseases, say researchers

Antibiotic combination effective against drug-resistant Pseudomonas

Collagen powder found to be effective in wound closure

ISTH introduces new global education initiative in gene therapy for hemophilia

New drug combinations and dosing schedules improve outlook in advanced colon cancer

Study suggests usefulness of more flexible dose of regorafenib to relieve side-effects in mCRC patients

Computer-generated flu vaccine enters clinical trials in the US

Hesperos' multi-organ model correctly determine cardiotoxic mechanisms

FDA grants accelerated approval to new treatment for refractory multiple myeloma

CMC expresses dismay at the findings of new report “Drugs policy: medicinal cannabis”

New telementoring program seeks to improve quality of care for breast cancer patients

Hypofractionated proton therapy for prostate cancer can be just as effective as standard treatment

Georgia State researcher wins $3.26 million federal grant to develop universal flu vaccine

Supplements claiming to boost brain health are 'too good to be true', warn experts

Study reveals lack of evidence for pediatric drugs prescribed to treat chronic pain

Pharmaceutical products made of solid gold

Disrupting ChIP Assay Technology with New Advancements

Are Chronic Pain Relief Drugs for Children Effective?

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News